The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics.
Anna Meta Dyrvig KristensenJohn MunkhaugenSigrun HalvorsenMichael Hecht OlsenArnhild BakkenThomas Steen Gyldenstierne SehestedVidar RuddoxTheis LangeMorten Wang FagerlandChristian Torp-PedersenEva Irene Bossano PrescottDan AtarPublished in: European heart journal. Cardiovascular pharmacotherapy (2023)
The combined BETAMI-DANBLOCK trial will have the potential to affect current clinical practice for beta-blocker therapy in patients with normal or mildly reduced LVEF after MI.